Addressing tumor blood vessels
- 1 June 1997
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 15 (6), 510
- https://doi.org/10.1038/nbt0697-510
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- αv Integrins as receptors for tumor targeting by circulating ligandsNature Biotechnology, 1997
- Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor VasculatureScience, 1997
- Discovery of TNP-470 and Other Angiogenesis InhibitorsPublished by Springer Nature ,1997
- Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor GrowthCell, 1997
- Clinical significance of the determination of angiogenesis in human breast cancer: Update of the biological background and overview of the vicenza studiesEuropean Journal Of Cancer, 1996
- Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas.Proceedings of the National Academy of Sciences, 1995
- Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vesselsCell, 1994
- Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti‐cancer therapeutic agentsBioEssays, 1991
- Vascular attack as a therapeutic strategy for cancerCancer and Metastasis Reviews, 1990